Type
GATE, ROUSSET. [Limitations of use of sulfone in treatment of leprosy]. Bulletin de la Societe francaise de dermatologie et de syphiligraphie. 1950;57(2):228-9.
Type
[Streptomycin in the treatment of leprosy]. Bulletin de la Societe francaise de dermatologie et de syphiligraphie. 1950;57(2):207-9.
Type
Basset, ALBAHARY. [A case of cutaneous lymph node leprosy]. Bulletin de la Societe francaise de dermatologie et de syphiligraphie. 1950;57(2):172-4.
Type
TISSEUIL. [Spontaneous premunition against tuberculosis has not, in New Caledonia and Guiana, given protection against leprosy]. Journal des praticiens; revue generale de clinique et de therapeutique. 1950;64(3):33-4.
Type
FLOCH, Destombes. [Practical superiority of diamino-diphenyl-sulfone (1358 F) over complex disubstituted sulfones in the treatment of leprosy]. Medecine tropicale : revue du Corps de sante colonial. 1950;10(1):61-72.
Type
LUTZ. [Infections diseases of the skin, with exception of dermatomycosis, tuberculosis and leprosy]. Dermatologica. 1950;101(1):56-63.
Type
Beland M, Soares G, Dubel G, Forte M, Murphy T. Endovascular repair of a thoracic aorta mycotic pseudoaneurysm in a patient with history of bacteroides fragilis sepsis and leprosy. Journal of vascular and interventional radiology : JVIR. 2005;16(2 Pt 1):298-300.
Type
Lahiri R, Randhawa B, Krahenbuhl J. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. Journal of medical microbiology. 2005;54(Pt 3):235-42.
Type
Zodpey. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy. Indian journal of public health. 2004;48(2):70-7.
Type
van Brakel WH, Lever P, Feenstra P. Monitoring the size of the leprosy problem: which epidemiological indicators should we use?. Indian journal of public health. 2004;48(1):5-16.